News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,987 Results
Type
Article (87430)
Company Profile (760)
Press Release (772774)
Multimedia
Podcasts (172)
Webinars (28)
Section
Business (233053)
Career Advice (4139)
Deals (39795)
Drug Delivery (136)
Drug Development (91249)
Employer Resources (203)
FDA (18284)
Job Trends (17399)
News (397389)
Policy (39926)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (125)
Alliances (56979)
ALS (146)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (244)
Approvals (18308)
Artificial intelligence (490)
Autoimmune disease (75)
Automation (26)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (161)
Biotechnology (484)
Bladder cancer (132)
Brain cancer (52)
Breast cancer (505)
Cancer (3966)
Cardiovascular disease (339)
Career advice (3556)
Career pathing (38)
CAR-T (247)
CDC (57)
Cell therapy (685)
Cervical cancer (33)
Clinical research (75530)
Collaboration (1387)
Company closure (4)
Compensation (939)
Complete response letters (59)
COVID-19 (2957)
CRISPR (81)
C-suite (591)
Cystic fibrosis (135)
Data (4503)
Decentralized trials (2)
Denatured (61)
Depression (112)
Diabetes (455)
Diagnostics (7091)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (234)
Drug pricing (190)
Drug shortages (36)
Duchenne muscular dystrophy (203)
Earnings (98805)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (133011)
Executive appointments (991)
FDA (20751)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1256)
Gene editing (173)
Generative AI (48)
Gene therapy (546)
GLP-1 (1020)
Government (5384)
Grass and pollen (7)
Guidances (342)
Healthcare (20937)
HIV (48)
Huntington's disease (38)
IgA nephropathy (63)
Immunology and inflammation (242)
Immuno-oncology (20)
Indications (53)
Infectious disease (3198)
Inflammatory bowel disease (188)
Inflation Reduction Act (15)
Influenza (97)
Intellectual property (190)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (16)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (572)
Lymphoma (265)
Machine learning (30)
Management (66)
Manufacturing (637)
MASH (140)
Medical device (14871)
Medtech (14894)
Mergers & acquisitions (22746)
Metabolic disorders (1158)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (229)
Neuropsychiatric disorders (60)
Neuroscience (2717)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (558)
Opinion (312)
Ovarian cancer (135)
Pain (166)
Pancreatic cancer (172)
Parkinson's disease (242)
Partnered (30)
Patents (420)
Patient recruitment (312)
Peanut (57)
People (66259)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23298)
Phase II (32787)
Phase III (24700)
Pipeline (2730)
Policy (295)
Postmarket research (3554)
Preclinical (10500)
Press Release (72)
Prostate cancer (201)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (674)
Real estate (7421)
Recruiting (78)
Regulatory (28017)
Reports (65)
Research institute (2690)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (71)
Schizophrenia (135)
Series A (207)
Series B (156)
Service/supplier (30)
Sickle cell disease (80)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (95)
The Weekly (109)
Vaccines (1048)
Venture capital (66)
Weight loss (396)
Women's health (59)
Worklife (21)
Date
Today (150)
Last 7 days (714)
Last 30 days (2578)
Last 365 days (33602)
2025 (26523)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50980)
Australia (8959)
California (9460)
Canada (2861)
China (903)
Colorado (402)
Connecticut (424)
Delaware (271)
Europe (117127)
Florida (1393)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (813)
India (51)
Indiana (461)
Iowa (19)
Japan (325)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (78)
Maryland (1278)
Massachusetts (7126)
Michigan (314)
Minnesota (563)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (108)
New Hampshire (77)
New Jersey (2632)
New Mexico (32)
New York (2579)
North Carolina (1412)
North Dakota (10)
Northern California (4280)
Ohio (297)
Oklahoma (22)
Oregon (50)
Pennsylvania (1967)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (49)
South Dakota (1)
Southern California (3615)
Tennessee (149)
Texas (1483)
United States (35002)
Utah (283)
Virginia (249)
Washington D.C. (83)
Washington State (819)
West Virginia (4)
Wisconsin (97)
Wyoming (1)
There are 860,987 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Systematic Review of 15 Studies Focused on Epidemiology and Antimicrobial Resistance of Pneumococcal Serotypes Covered by CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in U.S. Adults
October 21, 2025
·
9 min read
Press Releases
Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET
October 21, 2025
·
2 min read
Press Releases
XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
October 21, 2025
·
4 min read
Press Releases
SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform
October 21, 2025
·
13 min read
Press Releases
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
October 21, 2025
·
12 min read
Press Releases
PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
October 21, 2025
·
11 min read
Press Releases
Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers
October 21, 2025
·
3 min read
Press Releases
Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
October 21, 2025
·
7 min read
Press Releases
Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
October 21, 2025
·
3 min read
Press Releases
Alligator Bioscience Granted US Patent Covering ATOR-4066 Bispecific Antibody
October 21, 2025
·
2 min read
1 of 86,099
Next
